By the Jefferies Editorial Team At last year’s Global Healthcare Conference, interest in AI was beginning to surge. This year, it’s reached a fever pitch. A record one in four healthcare investment dollars is now going to companies leveraging AI. And AI is beginning to drive transaction activity in the sector, from IPOs like Tempus,
Jefferies unpacks the latest trends in pricing, product quality, and novel therapeutic approaches that are shaping an eventful 2024 for the sleep apnea treatment market.
For healthcare companies, balancing ESG concerns with an affordable and robust supply chain is a constant challenge. How do today’s healthcare leaders approach this balancing act?
Jefferies’ Global Research teams detail the possible implications for a slimmer consumer, with sticky behavioral changes, across 7 sectors. They identify ~80 companies that could benefit and ~80 that may find this a structural headwind.